Skip to main content
. 2020 Dec 17;10:574668. doi: 10.3389/fonc.2020.574668

Figure 3.

Figure 3

Kaplan-Meier curves showed overall survival (A) and Progression-free survival (B) in the S-TACE and complications of transarterial chemoembolization (TACE) groups in patients with early diffuse recurrence (EDR). Kaplan-Meier curves showed overall survival (C) and Progression-free survival (D) in the S-TACE and complications of transarterial chemoembolization (TACE) groups for patients with late diffuse recurrence (LDR).